Product Information
TRIAMCINOLONE 0.025% OINT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2392 per GM under NDC 33342033115. Its NADAC has been published 339 times since Apr 8, 2020.
FDA first approved this application on Nov 23, 2018. Its Orange Book therapeutic-equivalence code is AT.
Strength
.25 mg/g
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342033115
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209828FDA Approved
11/23/2018
TE Code
AT
On Market Since
11/23/2018
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 0.025% OINT has been published 339 times since Apr 8, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2392 per GM |
|---|---|
| All-time high | $0.2641 (Apr 13, 2022) |
| All-time low | $0.1654 (Nov 20, 2024) |
| 52-week high | $0.2515 |
| 52-week low | $0.2354 |
| Median price | $0.2414 |
| Average price | $0.2380 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 339 |
| Tracking since | Apr 8, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 0.025% OINT?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.025% OINT, manufactured by Macleods Pharmaceuticals Limited, is $0.2392 per GM (NDC 33342033115), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 0.025% OINT changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 0.025% OINT has held within roughly two percent of its current level. It has been tracked across 339 weekly CMS publications since Apr 8, 2020.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.025% OINT?
Since Apr 8, 2020, the NADAC for TRIAMCINOLONE 0.025% OINT has ranged from a low of $0.1654 (Nov 20, 2024) to a high of $0.2641 (Apr 13, 2022), with a median of $0.2414 per GM.
Are there cheaper alternatives to TRIAMCINOLONE 0.025% OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE 0.025% OINT, is $0.0471 per GM — about 80% below TRIAMCINOLONE 0.025% OINT.
Who manufactures TRIAMCINOLONE 0.025% OINT?
TRIAMCINOLONE 0.025% OINT (NDC 33342033115) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.